Life Whisperer Genetics AI is predictive of live birth outcomes
AI Healthcare company Presagen, in collaboration with Ovation Fertility (USA), presented a recent study on Life Whisperer at the American Society for Reproductive Medicine (ASRM) 2022 Scientific Congress, Oct 2022.
Life Whisperer uses Artificial Intelligence to assess images of IVF patients’ embryos to evaluate their quality, in order to improve IVF outcomes. Life Whisperer uses two AI algorithms. Life Whisperer Viability AI assesses how likely embryos are to lead to a pregnancy, and Life Whisperer Genetics AI non-invasively assesses embryo genetic integrity.
In a previous study, it was shown that Life Whisperer Genetics AI was able to predict whether an embryo was likely to be genetically normal, or euploid, just by analyzing an image of the embryo.
This recent finding showed that the same AI was also predictive of live birth. That is, embryos which Life Whisperer Genetics AI identified as highly likely to be euploid were much more likely to lead to a live birth for IVF patients.
This study is important for the IVF and AI industries because it further validates the potential for AI imaging to provide a non-invasive, low cost, and instant assessment of embryo genetic integrity to support IVF treatment.
Life Whisperer
Life Whisperer is a world-leader in the application of AI in IVF. The Life Whisperer Viability and Genetics AI-based embryo assessment tools are the first to be commercialized in a series of applications that encompass the complete IVF journey. Life Whisperer aims to improve IVF success rates at every point and, as a result, reduce time-to-pregnancy, making IVF more affordable and accessible to patients globally. Life Whisperer is being used in IVF clinics around the world.
Presagen
Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare products that are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership. With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.
